Pulse Brain · Growing Health Evidence Index
Tier 3 — Observational / field trialPeer-reviewed

Metabolomics Biomarkers for Fatty Acid Intake and Biomarker-Calibrated Fatty Acid Associations with Chronic Disease Risk in Postmenopausal Women

Ross L. Prentice, Sowmya Vasan, Lesley Fels Tinker, Marian L. Neuhouser, Sandi L. Navarro, Daniel Raftery, GA Nagana Gowda, Mary B. Pettinger, Aaron K. Aragaki, Johanna W. Lampe, Ying Huang, Linda Van Horn, JoAnn E. Manson, Robert B. Wallace, Yasmin Mossavar‐Rahmani, Jean Wactawski‐Wende, Simin Liu, Linda G. Snetselaar, Barbara V. Howard, Rowan T. Chlebowski, Cheng Zheng

Journal of Nutrition · 2023

Read source ↗ All evidence

Summary

This study developed and validated metabolomics-based biomarkers for major classes of dietary fatty acid intake in a large cohort of postmenopausal United States women (n=81,894), using serum and urine metabolite profiles calibrated against controlled feeding data. Higher saturated and polyunsaturated fatty acid densities showed weak or null associations with cardiovascular disease risk after controlling for other dietary factors, though positive associations were observed for some cancer types and type 2 diabetes. The findings suggest that observational associations between specific fatty acid classes and chronic disease in this population may be modest and sensitive to adjustment for related dietary factors.

Regional applicability

This study was conducted in the United States and enrolled postmenopausal women aged 50-79, so direct application to United Kingdom practice requires caution regarding age group applicability and dietary patterns. However, the metabolomics methodology and biomarker validation approach are transferable, and the null or weak associations with CVD risk align with recent United Kingdom and European dietary guidance questioning the strength of saturated fat restrictions for cardiovascular benefit.

Key measures

Serum and urine metabolite profiles; biomarker-calibrated fatty acid densities (SFA, MUFA, PUFA); hazard ratios for CVD, cancer, and T2D incidence

Outcomes reported

Development and validation of serum and urine metabolomics biomarkers for saturated, monounsaturated, and polyunsaturated fatty acid densities, and assessment of their associations with cardiovascular disease, cancer, and type 2 diabetes incidence over approximately 20 years of follow-up.

Theme
Nutrition & health
Subject
Dietary fats & fatty acids
Study type
Research
Study design
Observational cohort with embedded metabolomics calibration study
Source type
Peer-reviewed study
Status
Published
Geography
United States
System type
Human clinical
DOI
10.1016/j.tjnut.2023.05.003
Catalogue ID
SNmverv0zd-r394pw

Topic tags

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.